{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:13:31Z","timestamp":1790806411919,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007231","name":"Cancerf\u00f6reningen i Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ygyno.2016.10.039","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T15:00:20Z","timestamp":1478185220000},"page":"167-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6699-893X","authenticated-orcid":false,"given":"Pernilla","family":"Dahm-K\u00e4hler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Borgfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Staf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Falconer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bjurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preben","family":"Kj\u00f6lhede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"St\u00e5lberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"H\u00f6gberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"\u00c5vall-Lundqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2016.10.039_bb0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999\u20132007 by country and age: results of EUROCARE--5-a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2016.10.039_bb0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5694\/mja14.00132","article-title":"Survival of Australian women with invasive epithelial ovarian cancer: a population-based study","volume":"201","author":"Anuradha","year":"2014","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ygyno.2016.10.039_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020712-163949","article-title":"Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma","volume":"9","author":"Nik","year":"2014","journal-title":"Annu. Rev. Pathol."},{"issue":"11","key":"10.1016\/j.ygyno.2016.10.039_bb0020","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2016.10.039_bb0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3802\/jgo.2015.26.2.87","article-title":"FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication","volume":"26","author":"Prat","year":"2015","journal-title":"J. Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.10.039_bb0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2010.08.008","article-title":"Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971\/NCIC-CTG OV13 neoadjuvant trial","volume":"47","author":"Verleye","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.10.039_bb0035","doi-asserted-by":"crossref","first-page":"574540","DOI":"10.1155\/2015\/574540","article-title":"Pathologic assessment of rectal carcinoma after neoadjuvant radio(chemo)therapy: prognostic implications","volume":"2015","author":"Hav","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.ygyno.2016.10.039_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish cancer register: a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ygyno.2016.10.039_bb0085","series-title":"Nationell kvalitetsrapport f\u00f6r diagnos\u00e5ren 2010-Juni 2014","first-page":"1","author":"Gynekologisk cancer","year":"2015"},{"issue":"1","key":"10.1016\/j.ygyno.2016.10.039_bb0090","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0090-8258(03)00068-4","article-title":"Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study","volume":"89","author":"Bloss","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.10.039_bb0095","series-title":"World Health Organization Classification of Tumours","author":"Tavassoli","year":"2003"},{"issue":"1","key":"10.1016\/j.ygyno.2016.10.039_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004347-200001000-00003","article-title":"Histopathologic grading of ovarian carcinoma: a review and proposal","volume":"19","author":"Silverberg","year":"2000","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"Suppl 1","key":"10.1016\/j.ygyno.2016.10.039_bb0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0020-7292(03)90118-4","article-title":"Carcinoma of the ovary","volume":"83","author":"Heintz","year":"2003","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2016.10.039_bb0110","series-title":"\u00c4ggstockcancer Nationellt V\u00e5rdprogram","year":"2015"},{"issue":"Suppl 6","key":"10.1016\/j.ygyno.2016.10.039_bb0115","doi-asserted-by":"crossref","first-page":"vi24","DOI":"10.1093\/annonc\/mdt333","article-title":"Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Ledermann","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2016.10.039_bb0120","first-page":"101","article-title":"The relative survival rate: a statistical methodology","volume":"6","author":"Ederer","year":"1961","journal-title":"Natl. Cancer Inst. Monogr."},{"issue":"8","key":"10.1016\/j.ygyno.2016.10.039_bb0125","doi-asserted-by":"crossref","first-page":"644","DOI":"10.7326\/0003-4819-138-8-200304150-00012","article-title":"Multivariable analysis: a primer for readers of medical research","volume":"138","author":"Katz","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ygyno.2016.10.039_bb0130","series-title":"StataCorp. 2015 2015, Statistical Software","article-title":"StataCorp","author":"Station","year":"2015"},{"issue":"1","key":"10.1016\/j.ygyno.2016.10.039_bb0135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1536867X1501500112","article-title":"Estimating and modeling relative survival","volume":"15","author":"Dickman","year":"2015","journal-title":"Stata J."},{"issue":"1","key":"10.1016\/j.ygyno.2016.10.039_bb0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/jcp.55.1.27","article-title":"Morphological effects of chemotherapy on ovarian carcinoma","volume":"55","author":"McCluggage","year":"2002","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.10.039_bb0145","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ygyno.2016.04.026","article-title":"Non-surgical management of ovarian cancer: prevalence and implications","volume":"142","author":"Shalowitz","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.10.039_bb0150","series-title":"A National Cancer Strategy for the Future- Summary","year":"2009"},{"key":"10.1016\/j.ygyno.2016.10.039_bb0155","doi-asserted-by":"crossref","first-page":"f5569","DOI":"10.1136\/bmj.f5569","article-title":"Cancer care in the US needs a radical overhaul, says Institute of Medicine","volume":"347","author":"McCarthy","year":"2013","journal-title":"BMJ"},{"issue":"9972","key":"10.1016\/j.ygyno.2016.10.039_bb0160","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","article-title":"Global surveillance of cancer survival 1995\u20132009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)","volume":"385","author":"Allemani","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ygyno.2016.10.039_bb0165","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ajog.2014.08.016","article-title":"Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas","volume":"212","author":"Usach","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.10.039_bb0170","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ygyno.2014.08.020","article-title":"Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology\u2013a prospective comparative study","volume":"135","author":"Schnack","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.10.039_bb0175","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1158\/1055-9965.EPI-08-0771","article-title":"Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995\u20132004","volume":"18","author":"Goodman","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"Suppl 1","key":"10.1016\/j.ygyno.2016.10.039_bb0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/ijgc-00009577-200602001-00020","article-title":"Primary peritoneal carcinoma in a UK cancer center: comparison with advanced ovarian carcinoma over a 5-year period","volume":"16","author":"Jaaback","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2016.10.039_bb0185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.10.039_bb0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2015.10.022","article-title":"Primary site assignment in tubo-ovarian high-grade serous carcinoma: consensus statement on unifying practice worldwide","volume":"141","author":"Singh","year":"2016","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816315165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816315165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T13:37:35Z","timestamp":1620826655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816315165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0090825816315165"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.10.039","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}